Differences
This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision Next revision | Previous revision | ||
| neonatal_conjunctivitis [2026/02/16 21:25] – Scott Larson | neonatal_conjunctivitis [2026/02/16 21:27] (current) – [Treatment] Scott Larson | ||
|---|---|---|---|
| Line 47: | Line 47: | ||
| * substitute: cefotaxime 100 mg/kg IV or IM x 1 dose | * substitute: cefotaxime 100 mg/kg IV or IM x 1 dose | ||
| * Coinfection with the above two is common so combined treatment should be considered | * Coinfection with the above two is common so combined treatment should be considered | ||
| - | * Other bacteria: consider moxifloxicin TID or QID x 10 days with close follow-up | + | * Other bacteria: consider moxifloxicin TID or QID x 10 days guided by culture |
| + | * Viral- consider [[acyclovir|antiviral treatment]] for suspected HSV infection. | ||